In Vivo Confocal Microscopy Tumor Atlas Study
Sponsor: Carl Zeiss Surgical GmbH
Listed as NCT01012154, this PHASE1 trial focuses on Brain Neoplasms and remains ongoing. Sponsored by Carl Zeiss Surgical GmbH, it has been updated 5 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE1
-
Feb 2017 — Jan 2021 [monthly]
Unknown Status PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status PHASE1
First recorded
Nov 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Carl Zeiss Surgical GmbH
For direct contact, visit the study record on ClinicalTrials.gov .